All Pathways
PsychiatryEmergency

Acute Agitation Management (AAEP Project BETA)

Acute Agitation Management (AAEP Project BETA): Acute Agitation Identified → ⚠️ Staff Safety First → Verbal De-escalation (FIRST LINE) → De-escalation S...

Pathway Overview

15 steps

Algorithm Steps

15 total

  1. 01Start

    Acute Agitation Identified

    Patient presenting with agitation, aggression, or behavioral emergency

  2. 02Warning

    ⚠️ Staff Safety First

    Ensure adequate staff, clear exit routes, remove dangerous objects

    • Never approach alone
    • Maintain safe distance
    • Remove ties, lanyards, stethoscopes
    • Have security present
  3. 03Action

    Verbal De-escalation (FIRST LINE)

    Always attempt verbal de-escalation before medications

    • Speak calmly and slowly
    • Identify yourself and role
    • Offer choices when possible
    • Acknowledge patient's feelings
    • Avoid threatening body language
    • Maintain comfortable distance
  4. 04Decision

    De-escalation Successful?

    Assess if patient is responding to verbal intervention

  5. 05Outcome

    Agitation Controlled

    Continue monitoring, address underlying cause

  6. 06Decision

    Identify Likely Etiology

    Determine most likely cause of agitation

    • Psychiatric: psychosis, mania, personality disorder
    • Intoxication: alcohol, stimulants, PCP, anticholinergics
    • Withdrawal: alcohol, benzodiazepines, opioids
    • Medical: delirium, hypoglycemia, hypoxia, infection
  7. 07Action

    Primary Psychiatric (Psychosis/Mania)

    Antipsychotic-based regimen preferred

    • First line: Olanzapine 10mg IM OR Ziprasidone 20mg IM
    • Alternative: Haloperidol 5-10mg IM + Lorazepam 2mg IM
    • Droperidol 5-10mg IM if available (fastest onset)
    • Avoid benzodiazepine monotherapy
    • May repeat in 20-30 min if needed
  8. 08Decision

    Response to Initial Medication?

    Reassess 15-30 minutes after administration

  9. 09Action

    Post-Medication Monitoring

    Essential safety monitoring after sedation

    • Continuous pulse oximetry
    • Q15min vitals initially
    • Airway positioning (lateral if needed)
    • ECG if high-dose antipsychotics (QTc)
    • Have reversal agents available
  10. 10Outcome

    Patient Stabilized

    Transition to ongoing psychiatric/medical care

  11. 11Action

    Escalate Treatment

    If inadequate response after initial dose

    • Repeat same medication at same/higher dose
    • Add complementary agent (antipsychotic + benzodiazepine)
    • Consider ketamine 4-5mg/kg IM for severe agitation
    • Maximum haloperidol: 20mg/24hr recommended
    • Monitor for respiratory depression with combinations
  12. Path rejoins step 08Shared downstream outcome
  13. 12Warning

    Consider ICU/Higher Level of Care

    For refractory agitation or medical compromise

    • Propofol/dexmedetomidine infusion
    • Intubation if airway compromise
    • Continuous sedation monitoring
  14. 13Action

    Intoxication/Unknown Etiology

    Consider ketamine or combination therapy

    • Alcohol/unknown: Haloperidol 5mg + Lorazepam 2mg IM (B52)
    • Stimulants: Benzodiazepines preferred (Lorazepam 2-4mg IM)
    • Severe: Ketamine 4-5mg/kg IM (rapid onset)
    • PCP: Benzodiazepines, avoid antipsychotics if possible
    • Anticholinergic: Physostigmine if identified
  15. Path rejoins step 08Shared downstream outcome
  16. 14Action

    Withdrawal States

    Benzodiazepines are first-line

    • Alcohol/benzo withdrawal: Lorazepam 2-4mg IM/IV
    • May need high doses for severe withdrawal
    • Avoid antipsychotics (lower seizure threshold)
    • Monitor for seizures
    • Consider phenobarbital for refractory cases
  17. Path rejoins step 08Shared downstream outcome
  18. 15Warning

    Medical Delirium

    Treat underlying cause, use minimal sedation

    • Identify and treat underlying cause FIRST
    • Hypoglycemia: Dextrose
    • Hypoxia: Oxygen, airway management
    • Infection: Antibiotics, source control
    • If sedation needed: Low-dose haloperidol 0.5-2mg
    • Avoid benzodiazepines (may worsen delirium)
  19. Path rejoins step 08Shared downstream outcome

Guideline Source

The Psychopharmacology of Agitation: Consensus Statement of the AAEP Project BETA Psychopharmacology Workgroup

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Verbal de-escalation should ALWAYS be attempted first
  • Does not replace clinical judgment in specific contexts
  • Drug dosing may need adjustment for elderly or medically compromised
  • Specific antidotes/reversal agents not detailed
  • Pediatric dosing not included - requires specialist input

Contraindicated Populations

pediatric

Applicable Regions

USEUGlobal

EU: Haloperidol IV restricted in some countries due to QT risk

US: Droperidol availability varies by institution

Version 1Next review: 2028-01-01

Frequently Asked Questions

What is the Acute Agitation Management (AAEP Project BETA)?

The Acute Agitation Management (AAEP Project BETA) is a emergency clinical algorithm for Psychiatry. It provides a structured decision tree to guide clinical decision-making, based on The Psychopharmacology of Agitation: Consensus Statement of the AAEP Project BETA Psychopharmacology Workgroup.

What guideline is the Acute Agitation Management (AAEP Project BETA) based on?

This algorithm is based on The Psychopharmacology of Agitation: Consensus Statement of the AAEP Project BETA Psychopharmacology Workgroup (DOI: 10.5811/westjem.2011.9.6867).

What are the limitations of the Acute Agitation Management (AAEP Project BETA)?

Known limitations include: Verbal de-escalation should ALWAYS be attempted first; Does not replace clinical judgment in specific contexts; Drug dosing may need adjustment for elderly or medically compromised; Specific antidotes/reversal agents not detailed; Pediatric dosing not included - requires specialist input. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Acute Agitation Management (AAEP Project BETA) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free